References
- Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of Hip fractures in the United States. JAMA. 2009;302(14):1573–1579. doi:10.1001/jama.2009.1462
- Bekeris J, Wilson LA, Bekere D, et al. Trends in comorbidities and complications among patients undergoing hip fracture repair. Anesth Analg. 2021;132(2):475–484. doi:10.1213/ane.0000000000004519
- Meyer AC, Ek S, Drefahl S, Ahlbom A, Hedström M, Modig K. Trends in hip fracture incidence, recurrence, and survival by education and comorbidity: a Swedish register-based study. Epidemiology. 2021;32(3):425–433. doi:10.1097/ede.0000000000001321
- Schrøder CK, Hjelholt TJ, Møller H, Madsen M, Pedersen AB, Kristensen PK. Comorbidity and quality of in-hospital care for hip fracture patients. J Am Med Dir Assoc. 2022;23(4):671–677.e4. doi:10.1016/j.jamda.2022.01.078
- Pedersen AB, Ehrenstein V, Szepligeti SK, et al. Thirty-five-year trends in first-time hospitalization for hip fracture, 1-year mortality, and the prognostic impact of comorbidity: a Danish nationwide cohort study, 1980–2014. Epidemiology. 2017;28(6):898–905. doi:10.1097/EDE.0000000000000729
- Smith T, Pelpola K, Ball M, Ong A, Myint PK. Pre-operative indicators for mortality following Hip fracture surgery: a systematic review and meta-analysis. Age Ageing. 2014;43(4):464–471. doi:10.1093/ageing/afu065
- Jackson RD, Mysiw WJ. Insights into the epidemiology of postmenopausal osteoporosis: the women’s health initiative. Semin Reprod Med. 2014;32(6):454–462. doi:10.1055/s-0034-1384629
- Pratt NL, Kerr M, Barratt JD, et al. The validity of the Rx-Risk comorbidity index using medicines mapped to the anatomical therapeutic chemical (ATC) classification system. BMJ Open. 2018;8(4):e021122. doi:10.1136/bmjopen-2017-021122
- Vesterager JD, Madsen M, Hjelholt TJ, Kristensen PK, Pedersen AB. Prediction ability of Charlson, elixhauser, and rx-risk comorbidity indices for mortality in patients with hip fracture. A Danish population-based cohort study from 2014–2018. Clin Epidemiol. 2022;14:275–287. doi:10.2147/clep.S346745
- Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563. doi:10.2147/CLEP.S179083
- Kristensen PK, Rock ND, Christensen HC, Pedersen AB. The Danish multidisciplinary hip fracture registry 13-year results from a population-based cohort of hip fracture patients. Clin Epidemiol. 2020;12:9–21. doi:10.2147/clep.S231578
- Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
- Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, Sørensen HT, Hallas J, Schmidt M. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46(3):798–798f. doi:10.1093/ije/dyw213
- Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7 Suppl):103–105. doi:10.1177/1403494811405098
- Norredam M, Kastrup M, Helweg-Larsen K. Register-based studies on migration, ethnicity, and health. Scand J Public Health. 2011;39(7 Suppl):201–205. doi:10.1177/1403494810396561
- Kristensen PK, Thillemann TM, Pedersen AB, Soballe K, Johnsen SP. Socioeconomic inequality in clinical outcome among Hip fracture patients: a nationwide cohort study. Osteoporos Int. 2017;28(4):1233–1243. doi:10.1007/s00198-016-3853-7
- Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
- Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. doi:10.1097/00005650-199801000-00004
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
- Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83
- Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:11–83. doi:10.1186/1471-2288-11-83
- De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229. doi:10.1016/S0895-4356(02)00585-1
- van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Medical Care. 2009;47(6):626–633. doi:10.1097/MLR.0b013e31819432e5
- Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45(2):197–203. doi:10.1016/0895-4356(92)90016-g
- Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies conducted using observational routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885
- Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170(18):1648–1654. doi:10.1001/archinternmed.2010.355
- Sundhedsstyrrelsen. Seponeringslisten Anbefalinger til seponering af hyppigt anvendte lægemidler hos voksne. Available from: https://www.sst.dk/-/media/Udgivelser/2021/Seponeringsliste/SEPONERINGSLISTE_2022.ashx?la=da&hash=F48D9B0B0E1B0C3F00589DF7A56D9512FE34ECD1. Accessed January 31, 2022.
- Inacio MC, Pratt NL, Roughead EE, Graves SE. Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation. BMC Musculoskelet Disord. 2015;16:385. doi:10.1186/s12891-015-0835-4
- Lu CY, Barratt J, Vitry A, Roughead E. Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. J Clin Epidemiol. 2011;64(2):223–228. doi:10.1016/j.jclinepi.2010.02.015
- Lund JL, Frøslev T, Deleuran T, et al. Validity of the Danish national registry of patients for chemotherapy reporting among colorectal cancer patients is high. Clin Epidemiol. 2013;5:327–334. doi:10.2147/clep.S49773
- Swain S, Coupland C, Strauss V, et al. Clustering of comorbidities and associated outcomes in people with osteoarthritis - A UK Clinical Practice Research Datalink study. Osteoarthritis Cartilage. 2022;30(5):702–713. doi:10.1016/j.joca.2021.12.013
- Kirkland LL, Kashiwagi DT, Burton MC, Cha S, Varkey P. The Charlson comorbidity index score as a predictor of 30-day mortality after Hip fracture surgery. Am J Med Qual. 2011;26(6):461–467. doi:10.1177/1062860611402188
- Cher EWL, Allen JC, Howe TS, Koh JSB. Comorbidity as the dominant predictor of mortality after Hip fracture surgeries. Osteoporos Int. 2019;30(12):2477–2483. doi:10.1007/s00198-019-05139-8
- Toson B, Harvey LA, Close JC. The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following Hip fracture. J Clin Epidemiol. 2015;68(1):44–51. doi:10.1016/j.jclinepi.2014.09.017
- Kristensen KB, Lund LC, Jensen PB, et al. Development and validation of a Nordic multimorbidity index based on hospital diagnoses and filled prescriptions. Clin Epidemiol. 2022;14:567–579. doi:10.2147/clep.S353398
- Albertsen LW, Heide-Jørgensen U, Schmidt SAJ, et al. The DANish comorbidity index for acute myocardial infarction (DANCAMI): development, validation and comparison with existing comorbidity indices. Clin Epidemiol. 2020;12:1299. doi:10.2147/CLEP.S277325